Hepatitis C: IIb (IV) or not IIb (IV) that is the question | Zendy

Sallie Richard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Hepatitis C: IIb (IV) or not IIb (IV) that is the question

Author(s) -

Sallie Richard

Publication year - 1995

Publication title -

hepatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.488

H-Index - 361

eISSN - 1527-3350

pISSN - 0270-9139

DOI - 10.1002/hep.1840220245

Subject(s) - hepatocellular carcinoma , medicine , hepatitis c virus , cirrhosis , viremia , liver disease , hepatitis c , genotype , gastroenterology , immunology , antibody , interferon , virus , biology , biochemistry , gene

Objective : To analyze the distribution of hepatitis C virus (HCV) genotypes among patients positive for antibody to HCV (anti‐HCV) according to age, severity of liver disease, and duration of infection; to investigate the influence of HCV genotypes on response to interferon‐α therapy; and to study HCV viremia levels in relation to genotypes and severity of liver disease. Design : Cross‐sectional study. Setting : 3 university hospitals and 2 research units. Patients : 3 groups of French and Italian patients with chronic HCV infection and detectable serum HCV RNA: Group 1 included 35 patients with hepatocellular carcinoma; group 2, 71 patients with cirrhosis who did not have hepatocellular carcinoma; and group

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research